Scripps Research and Tempus are launching a study that uses genetic and other information to better understand what drives the development of obesity and...
The Food and Drug Administration (FDA) has approved Zegalogue® (dasiglucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged...